Suspicion mounts on Lilly Korea's outsourcing toward Zuellig Pharma Korea

Published: 2004-02-17 06:58:00

Updated: 2004-02-17 06:58:00

Pharmaceutical business sources said the plot re-thickens over alleged Lilly Korea's joining to Zuellig Pharma Korea, as its foreign president has strongly pushed for such plan after a defiant Korean executive resigned early this year.

Despite Lilly Korea's repeated denials on this matter so f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK